News

AlivaMab Discovery Services (ADS) Announces Agreement with Tanabe Research Laboratories USA

READ MORE

AlivaMab Discovery Services Announces Planned Leadership Transition

READ MORE

Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies

READ MORE

AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

READ MORE

AlivaMab Discovery Services Identifies Highly Potent Antibodies in Two Months for Inaugural Client Project

READ MORE

Webinars

Begin with the End in Mind:

Selection of an Antibody Discovery Platform

How the choice of therapeutic antibody discovery platform can impact downstream success in development and the market.

WATCH

2020 Conferences

BIO Digital

June 8-12, 2020

Corporate Fact Sheet

DOWNLOAD

Interviews

Nature speaks to Larry Green, CEO

Harnessing platform technology and expertise to fuel antibody drug discovery

DOWNLOAD

Pharmaceutical Executive speaks with Larry Green

From Mouse to Mab

READ